期刊文献+

血管紧张素Ⅱ对巨噬细胞表达肿瘤坏死因子转化酶的影响 被引量:1

Expression of Tumor Necrosis Factor-α Converting Enzyme mRNA in AngiotensinII-stimulated THP-1 Macrophages
下载PDF
导出
摘要 目的研究血管紧张素Ⅱ对经佛波酯分化的人急性白血病单核细胞表达肿瘤坏死因子转化酶mRNA的影响,探讨两者之间的联系,以进一步了解它们在动脉粥样硬化中的地位。方法将不同浓度血管紧张素Ⅱ(10-10~10-7mol/L)与经佛波酯(40nmol/L)分化后的人急性白血病单核细胞共孵育24h,以及将血管紧张素Ⅱ(10-7mol/L)与细胞作用不同时间(0、6、12、24和48h),采用半定量逆转录—聚合酶链反应法检测肿瘤坏死因子转化酶mRNA表达的情况。结果经佛波酯诱导后,人急性白血病单核细胞分化为巨噬细胞并表达肿瘤坏死因子转化酶mRNA。不同浓度的血管紧张素Ⅱ作用细胞24h,肿瘤坏死因子转化酶mRNA的表达呈浓度依赖性增加,差异具有显著性。血管紧张素Ⅱ(10-7mol/L)作用于细胞,呈时间依赖性诱导肿瘤坏死因子转化酶mRNA的表达,6h开始增加,24h达峰,之后逐渐减低,差异具有显著性。结论经佛波酯诱导分化后的人急性白血病单核细胞表达肿瘤坏死因子转化酶;血管紧张素Ⅱ呈浓度和时间依赖性上调巨噬细胞肿瘤坏死因子转化酶mRNA表达。血管紧张素Ⅱ与肿瘤坏死因子转化酶可能共同参与了血管壁炎症和动脉粥样硬化进展。 Aim To investigate the tumor necrosis factor-α converting enzyme (TACE) mRNA expression in angiotensinⅡ-stimulated THP-1 macrophages to explore the relationship and their potential roles in atherosclerosis. Methods Cultured THP-1 was differentiated with phorbol 12-myristate 13-acetate (PMA,40 nmol/L) for 24 hours to macrophages, then stimulated with AngⅡ in different concentration (10-10~10-7 mol/L) and for different time (0, 6, 12, 24 h and 48 h). RT-PCR was used to measure the expression of TACE mRNA. Results TACE mRNA was expressed in THP-1 after differentiated to macrophages by PMA. AngⅡ(10-10~10-7 mol/L) increased TACE mRNA expression in a dose dependent way (P<0.01 vs control; P<0.05 vs 10-7 mol/L). TACE mRNA was increased at 6 hours and with the highest level at 24 hours, then decreased (P<0.01 vs control; P<0.05 vs 24 h). Conclusions THP-1 macrophages express TACE. AngⅡsignificantly upregulates TACE expression in a dose-and-time dependent way. AngⅡand TACE may play an important role in macrophage-mediated vascular inflammation and atherosclerosis progression.
出处 《中国动脉硬化杂志》 CAS CSCD 2007年第3期197-200,共4页 Chinese Journal of Arteriosclerosis
关键词 病理与病理生理学 动脉粥样硬化 炎症 血管紧张素Ⅱ 佛波酯 巨噬细胞 肿瘤坏死因子转化酶 逆转录-聚合酶链反应 Atherosclerosis Inflammation AngiotensinII PMA Macrophages Tumor Necrosis Ffactor-α Converting Enzyme RT-PCR
  • 相关文献

参考文献12

  • 1[1]Nobuhiko A,Suganuma E,Babaev VR,Fogo A,Swift LL,Linton MF,et al.Angiotensin Ⅱ amplifies macrophage-driven atherosclerosis[J].Arterioscler Thromb Vasc Biol,2004,24:2 143-148.
  • 2[2]Arenas IA,Xu Y,Lopez-Jaramillo P,Davidge ST.Angiotensin Ⅱ-induced MMP-2 release from endothelial cells is mediated by TNF-α[J].Am J Physiol Cell Physiol,2004,286:C779-C784.
  • 3[3]Cui R,Tieu B,Recinos A,Tilton RG,Brasier AR.RhoA mediates angiotensin Ⅱ-induced phospho-Ser536 nuclear factor kappaB/RelA subunit exchange on the interleukin-6 promoter in VSMC[J].Circ Res,2006,99 (7):723-730.
  • 4[4]Fernandez-Real JM,Lainez B,Vendrell J,Rigla M,Castro A,Penarroja G,et al.Shedding of TNF-a receptors,blood pressure,and insulin sensitivity in type 2 diabetes mellitus[J].Am J Physiol Endocrinol Metab,2002,282:E952-E959.
  • 5[5]Canault M,Peiretti F,Kopp F,Bonardo B,Bonzi MF,Coudeyre JC,et al.The TNF alpha converting enzyme (TACE/ADAM17) is expressed in the atherosclerotic lesions of apolipoprotein E-deficient mice:possible contribution to elevated plasma levels of soluble TNF alpha receptors[J].Atherosclerosis,2006,187 (1):82-91.
  • 6吴超能,蒲晓群.血管紧张素Ⅱ、巨噬细胞与急性冠状动脉综合征[J].心血管病学进展,2004,25(6):447-449. 被引量:1
  • 7[7]Rival Y,Beneteau N,Chapuis V,Taillandier T,Lestienne F,Dupont-Passelaigue E,et al.Cardiovascular drugs inhibit MMP-9 activity from human THP-1 macrophages[J].DNA Cell Biol,2004,23 (5):283-292.
  • 8[8]Canault M,Peiretti F,Kopp F,Bonardo B,Bonzi MF,Coudeyre JC,et al.The TNF alpha converting enzyme (TACE/ADAM17) is expressed in the atherosclerotic lesions of apolipoprotein E-deficient mice:Possible contribution to elevated plasma levels of soluble TNF alpha receptors[J].Atherosclerosis,2006,187 (1):82-91.
  • 9[9]Valgimigli M,Ceconi C,Malagutti P,Merli E,Soukhomovskaia O,Francolini G,et al.Tumor necrosis factor-receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction:the cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study[J].Circulation,2005,111:863-870.
  • 10[10]Klouche M,Bhakdi S,Hemmes M,Rose-John S.Novel Path to Activation of Vascular Smooth Muscle Cells:Up-Regulation of gp130 Creates an Autocrine Activation Loop by IL-6 and Its Soluble Receptor[J].J Immunol,1999,163:4 583-589.

二级参考文献20

  • 1Keidar S,Heinrich R,Kaplan M,et al.Angiotensin Ⅱ administration to atherosclerotic mice increases macrophage uptake of oxidized LDL:a possible role for interleukin-6[J].Arterioscler Thromb Vasc Biol,2001,21(9):1461-1469.
  • 2Ni W,Kitamoto S,Ishibashi M,et al.Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin Ⅱ-induced progression of established atherosclerosis in hypercholesterolemic mice[J].Arterioscler Thromb Vasc Biol,2004,24(3):534-53
  • 3Cipollone F,Prontera C,Pini B,et al.Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E2-dependent plaque instability[J].Circulation,2001,104:921-927.
  • 4Cipollone F,Fazia M,Iezzi A,et al.Blockade of the angiotensin Ⅱ type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity[J].Circulation,2004,109:1482-1488.
  • 5Dezso B,Jacobsen J.Evidence for the presence of angiotensins in normal,unstimulated alveolar macrophages and monocytes[J].J Hypertens,1989,7(1):5-11.
  • 6Okamura A,Rakugi H,Ohishi M,et al.Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages[J].J Hypertens,1999,17(4):537-545.
  • 7Moreno PR,Falk E,Palacios IF,et al.Macrophage infiltration in acute coronary syndromes.Implications for plaque rupture[J].Circulation,1994,90:775-778.
  • 8Hayek T,Aviram M,Heinrich R,et al.Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients[J].Biochem Biophys Res Commun,2000,273(2):417-420.
  • 9Biswas P,Delfanti F,Bernasconi S,et al.Interleukin 6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line[J].Blood,1998,91:258-265.
  • 10Napoleone E,Di Santo A,Camera M,et al.Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes[J].Circ Res,2000,86(2):139-143.

同被引文献21

  • 1Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies [ J ]. Circulation, 2003, 108 (14) : 1 664-672.
  • 2Virmani R, Burke AP, Farb A, et al. Pathology of the vulnerable plaque [J]. J Am Coll Cardiol , 2006 , 47 ( S Suppl ) : C13-18.
  • 3Lusis AJ. Atherosclerosis [ J ]. Nature, 2000, 407 (6 801 ) : 233-241.
  • 4Major, TC, Liang L, Lu X, et al. Extracellular matrix metanoprotelnsse inducer (EMMPR/N) is induced upon monocyte differentiation and h expressed in human athetoma [ J ]. Arteriooscler Thromb Vasc Biol, 2002, 22 (7) : 1 200-207.
  • 5Fox KM. Efficacy of perlndopril in reduction of cardiovascular events among patient with stable coronary artely disease: nmdomised, double- blind, placebo-controlled, multicentre trial ( the EUROPA study) [J]. Lancet, 2003, 362 (9 386): 782-788.
  • 6Castoldl G, di Gioia CR, Travaglini C, et al. Angiotensin II increases tissue-specific inhibitor of metalloprotinase-2 expression in rat aortic smooth muscle cells in vivo: evidence of a pressurv-independent effect [J]. Clin Exp Pharmacol Physiol, 2007, 34 (3) : 205-209.
  • 7GuoBW, YangLX ,WangH, et al. Anglotensin II induces matrix metalloproteinsse-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells [J]. Regul Peps, 2008, 147 ( 1-3 ) : 37- 44.
  • 8Biswas C, Zhang Y, DeCastro R, et al. The human tumor cell-derived collagenase sfimulatory factor ( renamed EMMPRIN) is a member of the immunoglobulin superfamily [J]. Cancer Res, 1995, 55 (2) : 434-439.
  • 9Siwik, DA, Kuster GM, Brahmhhatt JV, et al. EMMPRIN mediates heta-adrenergic receptor-stimulated matrix metallioproteinase activity in cardiac myocytes [ J ]. J Mol Cell Cardiol, 2008, 44 ( 1 ) : 210-217.
  • 10Schmidt R, Bultmann A, Fisehel S, et al. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes [ J ]. Circ Res, 2008, 102 (3) : 302-309.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部